最新国产精品拍自在线观看_亚洲аv在线观看_老熟妇乱子伦视频在线试看_免费a级毛片18禁止免费网站

Global regulatory registration support

Efficient Registration Filling System

Rapid approval
Rapid approval
Rapid approval
US-based registration team communicates timely and regularly with FDA to achieve faster ANDA approval than other US competitors.
Professional declaration
Professional declaration
Our filling team has mastered the registration regulations and guidelines of various countries in the world. Our declaration projects support the filing of multi-regulation markets, covering China, the United States and Europe. Since 2021, Kingfriend has been the top1 domestic pharmaceutical company in terms of the number of approvals in the US.

by applying our efficient registration filing system, approval rate has increased year by year, up to 94%

/public/uploads/images/20220805/de7a1e25e802036cba529fbe40e33032.png
In order to improve the registration declaration， experts in Kingfriend have shared their knowledge and experience with staffs in the official accreditation body in China, and constantly summarized experience and improved methods, aiming at achieving a 100% approval rate.
Since 2017, a total of 77 projects have been declared in which 45 have been approved, reaching an approval rate of 56%. Plus, the approval rate is increasing year by year, reaching 94% in 2021.
At present, there over 10 projects being declared, over 10 research projects in progress, and over 10 projects in reserve.
Talk to our researchers about your project

Talk to our researchers about your project

Click to enter